Positive News SentimentPositive NewsNASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis $1.56 +0.03 (+1.96%) Closing price 07/29/2025 03:55 PM EasternExtended Trading$14.37 +12.81 (+821.15%) As of 05:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Envoy Medical Stock (NASDAQ:COCH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Envoy Medical alerts:Sign Up Key Stats Today's Range$1.52▼$1.5850-Day Range$1.37▼$1.7052-Week Range$1.21▼$3.99Volume5,747 shsAverage Volume28,715 shsMarket Capitalization$33.27 millionP/E RatioN/ADividend YieldN/APrice Target$9.25Consensus RatingBuy Company Overview Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota. Read More Envoy Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks55th Percentile Overall ScoreCOCH MarketRank™: Envoy Medical scored higher than 55% of companies evaluated by MarketBeat, and ranked 499th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEnvoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEnvoy Medical has only been the subject of 1 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Envoy Medical are expected to decrease in the coming year, from ($1.21) to ($1.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Envoy Medical is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Envoy Medical is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Envoy Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.08% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Envoy Medical has recently increased by 3.79%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.08% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Envoy Medical has recently increased by 3.79%, indicating that investor sentiment is decreasing. News and Social Media3.3 / 5News SentimentN/A News SentimentEnvoy Medical has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.04 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Envoy Medical this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for COCH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $82,430.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders58.90% of the stock of Envoy Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address COCH Stock News HeadlinesEnvoy Medical Draws Final $5 Million From GAT FundingJuly 15, 2025 | msn.comEnvoy Medical, Inc. (COCHW) stock price, news, quote & history ...July 11, 2025 | au.finance.yahoo.comAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and searches — are feeding the next wave of AI innovation. Big Tech is harvesting it. Mode Mobile is giving it back to you. They are creating a user-powered data economy that shares the upside, and +50M users have already generated +$325M in earnings. This isn't a theory… Mode’s 32,481% revenue growth from 2019-2022 landed them the #1 spot on Deloitte’s 2023 list of fastest growing companies in software, and they’ve secured the Nasdaq ticker $MODE ahead of a potential IPO. The offering could close any moment now. AI breakthroughs are everywhere, but these models need your data to survive. Invest in the company that allows you to share in the profits from yours.July 30 at 2:00 AM | Mode Mobile (Ad)Envoy Medical Inc Ordinary Shares - Class A COCHJuly 9, 2025 | morningstar.comMEnvoy Medical secures two new patents for implantable hearing techJuly 9, 2025 | uk.investing.comEnvoy Medical, Inc.: Envoy Medical Expands Patent Portfolio with New Issuances in the United StatesJuly 8, 2025 | finanznachrichten.deEnvoy Medical draws $5 million from credit line, issues warrant to GAT Funding - Investing.comJuly 3, 2025 | investing.comPleasing Signs As A Number Of Insiders Buy Envoy Medical StockJuly 2, 2025 | finance.yahoo.comSee More Headlines COCH Stock Analysis - Frequently Asked Questions How have COCH shares performed this year? Envoy Medical's stock was trading at $1.43 at the beginning of 2025. Since then, COCH stock has increased by 9.1% and is now trading at $1.56. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) announced its quarterly earnings results on Friday, March, 28th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.33) by $0.12. The firm had revenue of $0.04 million for the quarter, compared to analyst estimates of $0.07 million. Who are Envoy Medical's major shareholders? Envoy Medical's top institutional shareholders include NorthRock Partners LLC (48.25%). Insiders that own company stock include Brent T Lucas, Charles Brynelsen and Mona Chetan Patel. View institutional ownership trends. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Envoy Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPeng (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO), CrowdStrike (CRWD) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings3/28/2025Today7/30/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:COCH CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Price Target for Envoy Medical$9.25 High Price Target$9.50 Low Price Target$9.00 Potential Upside/Downside+492.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($1.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$20.80 million Net Margins-10,656.13% Pretax Margin-9,208.96% Return on EquityN/A Return on Assets-237.44% Debt Debt-to-Equity RatioN/A Current Ratio1.09 Quick Ratio0.88 Sales & Book Value Annual Sales$220 thousand Price / Sales151.25 Cash FlowN/A Price / Cash FlowN/A Book Value($0.88) per share Price / Book-1.77Miscellaneous Outstanding Shares21,330,000Free Float8,765,000Market Cap$33.27 million OptionableNot Optionable Beta2.22 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:COCH) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredSmall Cap- AI Hospitals = Big OpportunityA tiny NASDAQ firm just launched a generative AI platform aimed at disrupting a $2 trillion healthcare market....Smallcaps Daily | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.